Liquid Biopsy Research

At Genet, we are dedicated to advancing clinical cancer research by providing state-of-the-art liquid biopsy solutions that combine the power of NGS and dPCR. Our platform offers a non-invasive, precise, and comprehensive approach to cancer detection, monitoring, and treatment guidance, transforming the way we understand and manage this complex disease.

Liquid Biopsy Research Analytes: Genet’s liquid biopsy platform is capable of detecting various analytes, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and cancer-specific biomarkers, providing a more complete picture of tumor biology.

We are actively involved in a range of research areas, including early cancer detection, monitoring disease progression, minimal residual disease detection, and the development of personalized treatment strategies.

Liquid Biopsy Research Solutions

Contact Us